What are the major opportunities in the minimal residual disease testing market? What are the strategies for the minimal residual disease testing market?

For detailed insights on the major opportunities and strategies in the minimal residual disease testing market, Read More

How does the minimal residual disease testing market relate to the overall economy and other similar markets?

For detailed insights on minimal residual disease testing market's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the minimal residual disease testing market growth? SWOT analysis of the minimal residual disease testing market.

For detailed insights on the key dynamics influencing the minimal residual disease testing market growth and SWOT analysis of the minimal residual disease testing industry, Read More

Minimal Residual Disease Testing Market Global Report 2026 Market Report Infographic Image

Item added to cart!

Published : February 2026

Pages : 200

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Minimal Residual Disease Testing Market Report 2026

Name: Minimal Residual Disease Testing Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Test Type (DNA - Based Test, RNA- Based Test, Immunological Test), By Technology (Flow Cytometry, Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Other Technologies ), By Application (Hematological Malignancies, Leukemia, Lymphoma, Solid Tumors, Other Application), By End User (Hospitals And Specialty Clinics, Diagnostic Laboratories, Academic And Research Institutes, Other End Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Minimal Residual Disease Testing Market Overview

• Minimal Residual Disease Testing market size has reached to $1.8 billion in 2025

• Expected to grow to $3.31 billion in 2030 at a compound annual growth rate (CAGR) of 13.1%

• Growth Driver: Rising Cancer Prevalence Fueling Growth In Minimal Residual Disease Testing Market

• Market Trend: Advancements In Cancer Research Testing Enhance The Minimal Residual Disease Testing Market

• North America was the largest region in 2025.

What Is Covered Under Minimal Residual Disease Testing Market?

Minimal residual disease testing refers to a very sensitive test to detect cancer cells in the patient's body that may remain after treatment. It is used to monitor the effectiveness of cancer treatment and inform future treatment strategies.

The main test types of minimal residual disease testing are DNA - based tests, RNA- based tests, and immunological tests. DNA (deoxyribonucleic acid)-based testing (also known as genetic testing) is a type of medical examination that can spot changes to your chromosomes, genes, or proteins. The various technologies include flow cytometry, polymerase chain reaction (PCR), next-generation sequencing (NGS), and others, are used in various applications such as hematological malignancies, leukemia, lymphoma, solid tumors, and others. These are used by hospitals and specialty clinics, diagnostic laboratories, academic and research institutes, and others.

Minimal Residual Disease Testing Market Global Report 2026 Market Report bar graph

What Is The Minimal Residual Disease Testing Market Size and Share 2026?

The minimal residual disease testing market size has grown rapidly in recent years. It will grow from $1.8 billion in 2025 to $2.02 billion in 2026 at a compound annual growth rate (CAGR) of 12.5%. The growth in the historic period can be attributed to growing prevalence of hematological malignancies, advancements in molecular diagnostic technologies, rising awareness about minimal residual disease, increasing adoption of precision medicine, supportive government healthcare initiatives.

What Is The Minimal Residual Disease Testing Market Growth Forecast?

The minimal residual disease testing market size is expected to see rapid growth in the next few years. It will grow to $3.31 billion in 2030 at a compound annual growth rate (CAGR) of 13.1%. The growth in the forecast period can be attributed to technological advancements in nGS and digital PCR, expansion of cancer research funding, increasing collaborations between diagnostic and pharmaceutical companies, rising demand for personalized treatment monitoring, growth in emerging markets healthcare infrastructure. Major trends in the forecast period include liquid biopsy adoption, personalized cancer monitoring, early detection & prognosis improvement, integration of molecular diagnostics, expansion of oncology research.

Book your 30 minutes free consultation with our research experts

Global Minimal Residual Disease Testing Market Segmentation

1) By Test Type: DNA - Based Test, RNA- Based Test, Immunological Test

2) By Technology: Flow Cytometry, Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Other Technologies

3) By Application: Hematological Malignancies, Leukemia, Lymphoma, Solid Tumors, Other Application

4) By End User: Hospitals And Specialty Clinics, Diagnostic Laboratories, Academic And Research Institutes, Other End Users

Subsegments:

1) By DNA-Based Test: Polymerase Chain Reaction (PCR) Tests, Next-Generation Sequencing (NGS), Digital PCR

2) By RNA-Based Test: Reverse Transcription PCR (RT-PCR), RNA Sequencing, Quantitative PCR (qPCR)

3) By Immunological Test: Flow Cytometry, Enzyme-Linked Immunosorbent Assay (ELISA), Immunohistochemistry

What Is The Driver Of The Minimal Residual Disease Testing Market?

The increasing prevalence of cancer is expected to propel the growth of the minimal residual disease testing market going forward. Cancer refers to a condition when a few of the body's cells grow out of control and spread to other bodily regions. Cancer stages are primarily detected through minimal residual disease testing, which is a very sensitive method to detect cancer cells in the human body. It helps cancer patients prevent the disease at an early stage, boosting the minimal residual disease testing market. For instance, in January 2023, according to the National Institutes of Health (NIH), a U.S.-based government agency, in 2023, 1,958,310 new cancer cases and 609,820 cancer deaths are occured in the United States. Therefore, the increasing prevalence of cancer is driving the growth of the minimal residual disease testing industry.

Key Players In The Global Minimal Residual Disease Testing Market

Major companies operating in the minimal residual disease testing market are Natera Inc., Guardant Health Inc., Laboratory Corporation of America Holdings, QIAGEN NV, F. Hoffmann-La Roche Ltd., Bio-Techne Corporation, Bio-Rad Laboratories Inc., Sysmex Corporation, Exact Sciences Corporation, GRAIL LLC, Veracyte Inc., Cergentis B.V, Mdxhealth SA, NeoGenomics Laboratories Inc., Adaptive Biotechnologies, Thermo Fisher Scientific Inc., Siemens Healthineers AG, PerkinElmer Inc., Agilent Technologies Inc., ArcherDx Inc., Asuragen Inc., Becton Dickinson and Company, Cepheid Inc., Fluidigm Corporation, Illumina Inc., Invitae Corporation, Luminex Corporation, Menarini Silicon Biosystems S.p.A.

Global Minimal Residual Disease Testing Market Trends and Insights

Major companies in the minimal residual disease testing market are launching cancer research testing solutions to enhance detection sensitivity, improve treatment monitoring, and advance precision medicine approaches for better patient outcomes. The IDT Archer FUSIONPlex Core Solid Tumor Panel refers to a targeted next-generation sequencing assay used for detecting gene fusions and mutations in solid tumors, aiding in precision oncology and treatment decision-making. For instance, in April 2023, Integrated DNA Technologies (IDT), a US-based provider of genomic solutions, launched the IDT Archer FUSIONPlex Core Solid Tumor Panel, enhanced cancer research testing solution, now offering expanded and optimized coverage for single nucleotide variants (SNVs) and indels. This RNA-based sequencing assay simplifies fusion detection and variant calling in solid tumors, utilizing a single sample input and offering researchers a scalable, user-friendly solution that saves time, resources, and costs.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Minimal Residual Disease Testing Market?

In April 2023, Quest Diagnostics, a US-based clinical laboratory, acquired Haystack Oncology. With this acquisition Quest aims to improve personalized cancer care through Haystack's liquid biopsy technology. This approach detects residual or recurring cancer by identifying circulating tumor DNA (ctDNA) in the bloodstream. Haystack Oncology Inc is aUS-based biotechnology company.

Regional Insights

North America was the largest region in the minimal residual disease testing market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Minimal Residual Disease Testing Market?

The minimal residual disease testing market includes revenues earned by entities by providing services such as peripheral blood cell testing, sequencing testing, high-throughput sequencing testing, and methylation sequencing testing. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Minimal Residual Disease Testing Market Report 2026?

The minimal residual disease testing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the minimal residual disease testing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Minimal Residual Disease Testing Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$2.02 billion
Revenue Forecast In 2035	$3.31 billion
Growth Rate	CAGR of 12.5% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Test Type, Technology, Application, End User
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Natera Inc., Guardant Health Inc., Laboratory Corporation of America Holdings, QIAGEN NV, F. Hoffmann-La Roche Ltd., Bio-Techne Corporation, Bio-Rad Laboratories Inc., Sysmex Corporation, Exact Sciences Corporation, GRAIL LLC, Veracyte Inc., Cergentis B.
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Minimal Residual Disease Testing Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Minimal Residual Disease Testing Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Minimal Residual Disease Testing Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Minimal Residual Disease Testing Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Liquid Biopsy Adoption

4.2.2 Personalized Cancer Monitoring

4.2.3 Early Detection & Prognosis Improvement

4.2.4 Integration Of Molecular Diagnostics

4.2.5 Expansion Of Oncology Research

5. Minimal Residual Disease Testing Market Analysis Of End Use Industries

5.1 Hospitals And Specialty Clinics

5.2 Diagnostic Laboratories

5.3 Academic And Research Institutes

5.4 Oncology Centers

5.5 Biotechnology Companies

6. Minimal Residual Disease Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Minimal Residual Disease Testing Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Minimal Residual Disease Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Minimal Residual Disease Testing Market Size, Comparisons And Growth Rate Analysis

7.3. Global Minimal Residual Disease Testing Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Minimal Residual Disease Testing Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Minimal Residual Disease Testing Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Minimal Residual Disease Testing Market Segmentation

9.1. Global Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

DNA - Based Test, RNA- Based Test, Immunological Test

9.2. Global Minimal Residual Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Flow Cytometry, Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Other Technologies

9.3. Global Minimal Residual Disease Testing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hematological Malignancies, Leukemia, Lymphoma, Solid Tumors, Other Application

9.4. Global Minimal Residual Disease Testing Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals And Specialty Clinics, Diagnostic Laboratories, Academic And Research Institutes, Other End Users

9.5. Global Minimal Residual Disease Testing Market, Sub-Segmentation Of DNA-Based Test, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Polymerase Chain Reaction (PCR) Tests, Next-Generation Sequencing (NGS), Digital PCR

9.6. Global Minimal Residual Disease Testing Market, Sub-Segmentation Of RNA-Based Test, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Reverse Transcription PCR (RT-PCR), RNA Sequencing, Quantitative PCR (qPCR)

9.7. Global Minimal Residual Disease Testing Market, Sub-Segmentation Of Immunological Test, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Flow Cytometry, Enzyme-Linked Immunosorbent Assay (ELISA), Immunohistochemistry

10. Minimal Residual Disease Testing Market Regional And Country Analysis

10.1. Global Minimal Residual Disease Testing Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Minimal Residual Disease Testing Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Minimal Residual Disease Testing Market

11.1. Asia-Pacific Minimal Residual Disease Testing Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Minimal Residual Disease Testing Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Minimal Residual Disease Testing Market

12.1. China Minimal Residual Disease Testing Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Minimal Residual Disease Testing Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Minimal Residual Disease Testing Market

13.1. India Minimal Residual Disease Testing Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Minimal Residual Disease Testing Market

14.1. Japan Minimal Residual Disease Testing Market Overview

14.2. Japan Minimal Residual Disease Testing Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Minimal Residual Disease Testing Market

15.1. Australia Minimal Residual Disease Testing Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Minimal Residual Disease Testing Market

16.1. Indonesia Minimal Residual Disease Testing Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Minimal Residual Disease Testing Market

17.1. South Korea Minimal Residual Disease Testing Market Overview

17.2. South Korea Minimal Residual Disease Testing Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Minimal Residual Disease Testing Market

18.1. Taiwan Minimal Residual Disease Testing Market Overview

18.2. Taiwan Minimal Residual Disease Testing Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Minimal Residual Disease Testing Market

19.1. South East Asia Minimal Residual Disease Testing Market Overview

19.2. South East Asia Minimal Residual Disease Testing Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Minimal Residual Disease Testing Market

20.1. Western Europe Minimal Residual Disease Testing Market Overview

20.2. Western Europe Minimal Residual Disease Testing Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Minimal Residual Disease Testing Market

21.1. UK Minimal Residual Disease Testing Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Minimal Residual Disease Testing Market

22.1. Germany Minimal Residual Disease Testing Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Minimal Residual Disease Testing Market

23.1. France Minimal Residual Disease Testing Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Minimal Residual Disease Testing Market

24.1. Italy Minimal Residual Disease Testing Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Minimal Residual Disease Testing Market

25.1. Spain Minimal Residual Disease Testing Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Minimal Residual Disease Testing Market

26.1. Eastern Europe Minimal Residual Disease Testing Market Overview

26.2. Eastern Europe Minimal Residual Disease Testing Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Minimal Residual Disease Testing Market

27.1. Russia Minimal Residual Disease Testing Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Minimal Residual Disease Testing Market

28.1. North America Minimal Residual Disease Testing Market Overview

28.2. North America Minimal Residual Disease Testing Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Minimal Residual Disease Testing Market

29.1. USA Minimal Residual Disease Testing Market Overview

29.2. USA Minimal Residual Disease Testing Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Minimal Residual Disease Testing Market

30.1. Canada Minimal Residual Disease Testing Market Overview

30.2. Canada Minimal Residual Disease Testing Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Minimal Residual Disease Testing Market

31.1. South America Minimal Residual Disease Testing Market Overview

31.2. South America Minimal Residual Disease Testing Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Minimal Residual Disease Testing Market

32.1. Brazil Minimal Residual Disease Testing Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Minimal Residual Disease Testing Market

33.1. Middle East Minimal Residual Disease Testing Market Overview

33.2. Middle East Minimal Residual Disease Testing Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Minimal Residual Disease Testing Market

34.1. Africa Minimal Residual Disease Testing Market Overview

34.2. Africa Minimal Residual Disease Testing Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Minimal Residual Disease Testing Market Regulatory and Investment Landscape

36. Minimal Residual Disease Testing Market Competitive Landscape And Company Profiles

36.1. Minimal Residual Disease Testing Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Minimal Residual Disease Testing Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Minimal Residual Disease Testing Market Company Profiles

36.3.1. Natera Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Guardant Health Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Laboratory Corporation of America Holdings Overview, Products and Services, Strategy and Financial Analysis

36.3.4. QIAGEN NV Overview, Products and Services, Strategy and Financial Analysis

36.3.5. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis

37. Minimal Residual Disease Testing Market Other Major And Innovative Companies

Bio-Techne Corporation, Bio-Rad Laboratories Inc., Sysmex Corporation, Exact Sciences Corporation, GRAIL LLC, Veracyte Inc., Cergentis B.V, Mdxhealth SA, NeoGenomics Laboratories Inc., Adaptive Biotechnologies, Thermo Fisher Scientific Inc., Siemens Healthineers AG, PerkinElmer Inc., Agilent Technologies Inc., ArcherDx Inc.

38. Global Minimal Residual Disease Testing Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Minimal Residual Disease Testing Market

40. Minimal Residual Disease Testing Market High Potential Countries, Segments and Strategies

40.1 Minimal Residual Disease Testing Market In 2030 - Countries Offering Most New Opportunities

40.2 Minimal Residual Disease Testing Market In 2030 - Segments Offering Most New Opportunities

40.3 Minimal Residual Disease Testing Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Minimal Residual Disease Testing Market, Overview Of Key Products - Product Examples

Table 2: Global Minimal Residual Disease Testing Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Minimal Residual Disease Testing Market, Supply Chain Analysis

Table 4: Global Minimal Residual Disease Testing Market, Major Raw Material Providers

Table 5: Global Minimal Residual Disease Testing Market, Major Resource Providers

Table 6: Global Minimal Residual Disease Testing Market, Major Manufacturers (Suppliers)

Table 7: Global Minimal Residual Disease Testing Market, Major Distributors And Channel Partners

Table 8: Global Minimal Residual Disease Testing Market, Key Technologies & Future Trends

Table 9: Global Minimal Residual Disease Testing Market, Major Trends

Table 10: Global Minimal Residual Disease Testing Market, Major End Users

Table 11: Global Minimal Residual Disease Testing Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Minimal Residual Disease Testing Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Minimal Residual Disease Testing Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Minimal Residual Disease Testing Market - TAM, US$ Billion, 2025

Table 15: Global Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Minimal Residual Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Minimal Residual Disease Testing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Minimal Residual Disease Testing Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Minimal Residual Disease Testing Market, Sub-Segmentation Of DNA-Based Test, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Minimal Residual Disease Testing Market, Sub-Segmentation Of RNA-Based Test, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Minimal Residual Disease Testing Market, Sub-Segmentation Of Immunological Test, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Minimal Residual Disease Testing Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Minimal Residual Disease Testing Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Asia-Pacific, Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Asia-Pacific, Minimal Residual Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, Minimal Residual Disease Testing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: China, Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: China, Minimal Residual Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, Minimal Residual Disease Testing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: India, Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: India, Minimal Residual Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, Minimal Residual Disease Testing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: Japan, Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Japan, Minimal Residual Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, Minimal Residual Disease Testing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Australia, Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Australia, Minimal Residual Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, Minimal Residual Disease Testing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Indonesia, Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Indonesia, Minimal Residual Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, Minimal Residual Disease Testing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: South Korea, Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: South Korea, Minimal Residual Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, Minimal Residual Disease Testing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Taiwan, Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Taiwan, Minimal Residual Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, Minimal Residual Disease Testing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: South East Asia, Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: South East Asia, Minimal Residual Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia, Minimal Residual Disease Testing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Western Europe, Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Western Europe, Minimal Residual Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, Minimal Residual Disease Testing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: UK, Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: UK, Minimal Residual Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, Minimal Residual Disease Testing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: Germany, Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: Germany, Minimal Residual Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, Minimal Residual Disease Testing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: France, Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: France, Minimal Residual Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, Minimal Residual Disease Testing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: Italy, Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Italy, Minimal Residual Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, Minimal Residual Disease Testing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Spain, Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Spain, Minimal Residual Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, Minimal Residual Disease Testing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Eastern Europe, Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Eastern Europe, Minimal Residual Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, Minimal Residual Disease Testing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Russia, Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Russia, Minimal Residual Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, Minimal Residual Disease Testing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: North America, Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: North America, Minimal Residual Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, Minimal Residual Disease Testing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: USA, Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: USA, Minimal Residual Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, Minimal Residual Disease Testing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: Canada, Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: Canada, Minimal Residual Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, Minimal Residual Disease Testing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: South America, Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: South America, Minimal Residual Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, Minimal Residual Disease Testing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: Brazil, Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Brazil, Minimal Residual Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, Minimal Residual Disease Testing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Middle East, Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Middle East, Minimal Residual Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, Minimal Residual Disease Testing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Africa, Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Africa, Minimal Residual Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, Minimal Residual Disease Testing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Global Minimal Residual Disease Testing Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 97: Global Minimal Residual Disease Testing Market - Company Scoring Matrix

Table 98: Natera Inc. Financial Performance

Table 99: Guardant Health Inc. Financial Performance

Table 100: Laboratory Corporation of America Holdings Financial Performance

Table 101: QIAGEN NV Financial Performance

Table 102: F. Hoffmann-La Roche Ltd. Financial Performance

Table 103: Global Minimal Residual Disease Testing Market, Competitive Benchmarking (In USD Billions)

Table 104: Global Minimal Residual Disease Testing Market, Competitive Dashboard

Table 105: Global Minimal Residual Disease Testing Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 106: Global, Minimal Residual Disease Testing Market Size Gain ($ Billion), Segmentation By Test Type, 2025 – 2030

Table 107: Global, Minimal Residual Disease Testing Market Size Gain ($ Billion), Segmentation By Technology, 2025 – 2030

Table 108: Global, Minimal Residual Disease Testing Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

List Of Figures

Figure 1: Global Minimal Residual Disease Testing Market, Overview Of Key Products - Product Examples

Figure 2: Global Minimal Residual Disease Testing Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Minimal Residual Disease Testing Market, Supply Chain Analysis

Figure 4: Global Minimal Residual Disease Testing Market, Major Raw Material Providers

Figure 5: Global Minimal Residual Disease Testing Market, Major Resource Providers

Figure 6: Global Minimal Residual Disease Testing Market, Major Manufacturers (Suppliers)

Figure 7: Global Minimal Residual Disease Testing Market, Major Distributors And Channel Partners

Figure 8: Global Minimal Residual Disease Testing Market, Key Technologies & Future Trends

Figure 9: Global Minimal Residual Disease Testing Market, Major Trends

Figure 10: Global Minimal Residual Disease Testing Market, Major End Users

Figure 11: Global Minimal Residual Disease Testing Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Minimal Residual Disease Testing Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Minimal Residual Disease Testing Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Minimal Residual Disease Testing Market - TAM, US$ Billion, 2025

Figure 15: Global Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Minimal Residual Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Minimal Residual Disease Testing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Minimal Residual Disease Testing Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Minimal Residual Disease Testing Market, Sub-Segmentation Of DNA-Based Test, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Minimal Residual Disease Testing Market, Sub-Segmentation Of RNA-Based Test, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Minimal Residual Disease Testing Market, Sub-Segmentation Of Immunological Test, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Minimal Residual Disease Testing Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Minimal Residual Disease Testing Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Asia-Pacific, Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Asia-Pacific, Minimal Residual Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, Minimal Residual Disease Testing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: China, Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: China, Minimal Residual Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, Minimal Residual Disease Testing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: India, Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: India, Minimal Residual Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, Minimal Residual Disease Testing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: Japan, Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Japan, Minimal Residual Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, Minimal Residual Disease Testing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Australia, Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Australia, Minimal Residual Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, Minimal Residual Disease Testing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Indonesia, Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Indonesia, Minimal Residual Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, Minimal Residual Disease Testing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: South Korea, Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: South Korea, Minimal Residual Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, Minimal Residual Disease Testing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Taiwan, Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Taiwan, Minimal Residual Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, Minimal Residual Disease Testing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: South East Asia, Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: South East Asia, Minimal Residual Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia, Minimal Residual Disease Testing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Western Europe, Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Western Europe, Minimal Residual Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, Minimal Residual Disease Testing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: UK, Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: UK, Minimal Residual Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, Minimal Residual Disease Testing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: Germany, Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: Germany, Minimal Residual Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, Minimal Residual Disease Testing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: France, Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: France, Minimal Residual Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, Minimal Residual Disease Testing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: Italy, Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Italy, Minimal Residual Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, Minimal Residual Disease Testing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Spain, Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Spain, Minimal Residual Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, Minimal Residual Disease Testing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Eastern Europe, Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Eastern Europe, Minimal Residual Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, Minimal Residual Disease Testing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Russia, Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Russia, Minimal Residual Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, Minimal Residual Disease Testing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: North America, Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: North America, Minimal Residual Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, Minimal Residual Disease Testing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: USA, Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: USA, Minimal Residual Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, Minimal Residual Disease Testing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: Canada, Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: Canada, Minimal Residual Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, Minimal Residual Disease Testing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: South America, Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: South America, Minimal Residual Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, Minimal Residual Disease Testing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: Brazil, Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Brazil, Minimal Residual Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, Minimal Residual Disease Testing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Middle East, Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Middle East, Minimal Residual Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, Minimal Residual Disease Testing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Africa, Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Africa, Minimal Residual Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, Minimal Residual Disease Testing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Global Minimal Residual Disease Testing Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 97: Global Minimal Residual Disease Testing Market - Company Scoring Matrix

Figure 98: Natera Inc. Financial Performance

Figure 99: Guardant Health Inc. Financial Performance

Figure 100: Laboratory Corporation of America Holdings Financial Performance

Figure 101: QIAGEN NV Financial Performance

Figure 102: F. Hoffmann-La Roche Ltd. Financial Performance

Figure 103: Global Minimal Residual Disease Testing Market, Competitive Benchmarking (In USD Billions)

Figure 104: Global Minimal Residual Disease Testing Market, Competitive Dashboard

Figure 105: Global Minimal Residual Disease Testing Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 106: Global, Minimal Residual Disease Testing Market Size Gain ($ Billion), Segmentation By Test Type, 2025 – 2030

Figure 107: Global, Minimal Residual Disease Testing Market Size Gain ($ Billion), Segmentation By Technology, 2025 – 2030

Figure 108: Global, Minimal Residual Disease Testing Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

Latest Market Developments in Antacids Industry: Forecast 2025–2029

2025–2029 Anti-Asthmatics And COPD Drugs Market Outlook: Regional Trends and Growth Forecast

Future Demand and Leading Companies Shaping the Antibody Drug Conjugates Market to 2029

Global Antidepressants Market Projected to Reach $19.92 Billion by 2029 at a CAGR of 2.7%

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

Discover key trends and market dynamics in the Mycobacterium Tuberculosis Market with 2025 insights from The Business Research Company.

Discover key trends and market dynamics in the Smoking Cessation & Nicotine De-addiction Products Market with 2025 insights from The Business Research Company.

Rare Disease Diagnostics Market Report 2026 - Global Outlook – By Test Type (Genetic Test, General Lab Test, Imaging Test), By Technology (Capillary Sequencing, Whole Genome Sequencing, Whole Exome Sequencing, Microarray...

Infectious Disease Diagnostics Testing Market Report 2026 - Global Outlook – By Type (Molecular Diagnostic Test, Point Of Care Tests (POCT) Infectious Disease Diagnostics Test), By Application (Respiratory, Human Immunod...

Clinical Diagnostics Market Report 2026 - Global Outlook – By Test (Lab Test, Imaging Test, Other Tests), By Product (Instruments, Reagents, Other Products ), By End User (Hospital Laboratory, Diagnostic Laboratory, Poin...

Companion Diagnostics Market Report 2026 - Global Outlook – By Product And Service (Assays, Kits And Reagents, Software And Services), By Technology (Polymerase Chain Reaction, Next-Generation Sequencing, In Situ Hybridi...

Respiratory Disease Testing Market Report 2026 - Global Outlook – By Test Type (Imaging Tests, Mechanical Tests, In-Vitro Diagnostic Tests), By Products (Lung Volume, Imaging, Spirometry, Peak Flow, Blood Gas, Other Prod...

Point of Care Diagnostics Market Report 2026 - Global Outlook – By Product (Glucose Monitoring Kits, Infectious Diseases Testing Kits, Pregnancy And Fertility Testing Kits, Hematology Testing Kits, Cardiometabolic Monito...

Precision Diagnostics Market Report 2026 - Global Outlook – By Type (Genetic Tests, Esoteric tests, Other Types), By Technology (Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), In Situ Hybridization (I...

Frequently Asked Questions

How big is the Minimal Residual Disease Testing Market?

The Minimal Residual Disease Testing market was valued at $1.8 billion in 2025, increased to $2.02 billion in 2026, and is projected to reach $3.31 billion by 2030. request a sample here

What is the Minimal Residual Disease Testing market growth?

The global Minimal Residual Disease Testing market is expected to grow at a CAGR of 13.1% from 2026 to 2035 to reach $3.31 billion by 2035. request a sample here

Who are the key players in Minimal Residual Disease Testing market?

Some Key Players in the Minimal Residual Disease Testing market Include, Natera Inc., Guardant Health Inc., Laboratory Corporation of America Holdings, QIAGEN NV, F. Hoffmann-La Roche Ltd., Bio-Techne Corporation, Bio-Rad Laboratories Inc., Sysmex Corporation, Exact Sciences Corporation, GRAIL LLC, Veracyte Inc., Cergentis B.V, Mdxhealth SA, NeoGenomics Laboratories Inc., Adaptive Biotechnologies, Thermo Fisher Scientific Inc., Siemens Healthineers AG, PerkinElmer Inc., Agilent Technologies Inc., ArcherDx Inc., Asuragen Inc., Becton Dickinson and Company, Cepheid Inc., Fluidigm Corporation, Illumina Inc., Invitae Corporation, Luminex Corporation, Menarini Silicon Biosystems S.p.A. . request a sample here

What is the anticipated growth trend for the Minimal Residual Disease Testing market?

Major trend in this market includes: Advancements In Cancer Research Testing Enhance The Minimal Residual Disease Testing Market. For further insights on this market. request a sample here

Which region has the most growth potential in the Minimal Residual Disease Testing market?

North America was the largest region in the minimal residual disease testing market in 2025. The regions covered in the minimal residual disease testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. request a sample here.

Who are the key players in the Minimal Residual Disease Testing Market Report 2026 market?

Major companies operating in the Minimal Residual Disease Testing Market Report 2026 market are Major companies operating in the minimal residual disease testing market are Natera Inc., Guardant Health Inc., Laboratory Corporation of America Holdings, request a sample here.

Book your 30 minutes free consultation with our research experts

Contact Us